Plasmodium infection induces cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein
dc.contributor.author | Lapidus, Sarah | |
dc.contributor.author | Liu, Feimei | |
dc.contributor.author | Casanovas-Massana, Arnau | |
dc.date.accessioned | 2023-06-09T18:23:52Z | |
dc.date.available | 2023-06-09T18:23:52Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Individuals with acute malaria infection generated high levels of antibodies that cross-react with the SARS-CoV-2 Spike protein. Cross-reactive antibodies specifically recognized the sialic acid moiety on N-linked glycans of the Spike protein and do not neutralize in vitro SARS-CoV-2. Sero-surveillance is critical for monitoring and projecting disease burden and risk during the pandemic; however, routine use of Spike protein-based assays may overestimate SARS-CoV-2 exposure and population-level immunity in malaria-endemic countries | en_US |
dc.description.sponsorship | ACE: Bio-technological Innovation for the Elimination of Vector- Borne Diseases | en_US |
dc.identifier.issn | 2475-9066 | |
dc.identifier.uri | http://hdl.handle.net/123456789/1936 | |
dc.language.iso | en | en_US |
dc.publisher | medRxiv | en_US |
dc.relation.ispartofseries | medRxiv; | |
dc.subject | Yile Da | en_US |
dc.subject | John D. Huc | en_US |
dc.subject | Carolina Lucas | en_US |
dc.subject | Plasmodium | en_US |
dc.subject | ACE: Bio-technological Innovation for the Elimination of Vector- Borne Diseases | en_US |
dc.subject | Université Nazi Boni | en_US |
dc.subject | CEA-ITECH_MTV | en_US |
dc.title | Plasmodium infection induces cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein | en_US |